107 related articles for article (PubMed ID: 33745605)
21. Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease.
Shida T; Akiyama K; Oh S; Sawai A; Isobe T; Okamoto Y; Ishige K; Mizokami Y; Yamagata K; Onizawa K; Tanaka H; Iijima H; Shoda J
J Gastroenterol; 2018 Apr; 53(4):535-547. PubMed ID: 28791501
[TBL] [Abstract][Full Text] [Related]
22. No Muscle Depletion with High Visceral Fat as a Novel Beneficial Biomarker of Sorafenib for Hepatocellular Carcinoma.
Saeki I; Yamasaki T; Maeda M; Kawano R; Hisanaga T; Iwamoto T; Matsumoto T; Hidaka I; Ishikawa T; Takami T; Sakaida I
Liver Cancer; 2018 Oct; 7(4):359-371. PubMed ID: 30488024
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials.
Charette N; Vandeputte C; Ameye L; Bogaert CV; Krygier J; Guiot T; Deleporte A; Delaunoit T; Geboes K; Van Laethem JL; Peeters M; Demolin G; Holbrechts S; Flamen P; Paesmans M; Hendlisz A
BMC Cancer; 2019 Feb; 19(1):134. PubMed ID: 30744591
[TBL] [Abstract][Full Text] [Related]
24. U-shaped relationship between subcutaneous adipose tissue index and mortality in liver cirrhosis.
Zhu M; Li H; Yin Y; Ding M; Philips CA; Romeiro FG; Qi X
J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):508-516. PubMed ID: 36577511
[TBL] [Abstract][Full Text] [Related]
25. Sarcopenia and visceral obesity assessed by computed tomography are associated with adverse outcomes in patients with Crohn's disease.
Grillot J; D'Engremont C; Parmentier AL; Lakkis Z; Piton G; Cazaux D; Gay C; De Billy M; Koch S; Borot S; Vuitton L
Clin Nutr; 2020 Oct; 39(10):3024-3030. PubMed ID: 31980183
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for small bowel angioectasia: The impact of visceral fat accumulation.
Yamada A; Niikura R; Kobayashi Y; Suzuki H; Yoshida S; Watabe H; Yamaji Y; Hirata Y; Koike K
World J Gastroenterol; 2015 Jun; 21(23):7242-7. PubMed ID: 26109811
[TBL] [Abstract][Full Text] [Related]
27. Visceral fat is associated with cirrhotic portal vein thrombosis.
Hernández-Conde M; Llop E; Fernández-Carrillo C; Perelló C; López-Gómez M; Abad J; Martínez-Porras JL; Fernández-Puga N; Calleja JL
Expert Rev Gastroenterol Hepatol; 2019 Oct; 13(10):1017-1022. PubMed ID: 31393183
[No Abstract] [Full Text] [Related]
28. Excessive visceral fat area as a risk factor for early postoperative complications of total gastrectomy for gastric cancer: a retrospective cohort study.
Takeuchi M; Ishii K; Seki H; Yasui N; Sakata M; Shimada A; Matsumoto H
BMC Surg; 2016 Aug; 16(1):54. PubMed ID: 27494994
[TBL] [Abstract][Full Text] [Related]
29. The relationship between non-alcoholic fatty liver and skeletal muscle mass to visceral fat area ratio in women with type 2 diabetes.
Su X; Xu J; Zheng C
BMC Endocr Disord; 2019 Jul; 19(1):76. PubMed ID: 31315613
[TBL] [Abstract][Full Text] [Related]
30. Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation.
Kamo N; Kaido T; Hamaguchi Y; Okumura S; Kobayashi A; Shirai H; Yao S; Yagi S; Uemoto S
Clin Nutr; 2019 Oct; 38(5):2202-2209. PubMed ID: 30482562
[TBL] [Abstract][Full Text] [Related]
31. Visceral fat obesity is highly associated with primary gout in a metabolically obese but normal weighted population: a case control study.
Lee J; Lee JY; Lee JH; Jung SM; Suh YS; Koh JH; Kwok SK; Ju JH; Park KS; Park SH
Arthritis Res Ther; 2015 Mar; 17(1):79. PubMed ID: 25889813
[TBL] [Abstract][Full Text] [Related]
32. Effects of visceral fat area and other metabolic parameters on stone composition in patients undergoing percutaneous nephrolithotomy.
Zhou T; Watts K; Agalliu I; DiVito J; Hoenig DM
J Urol; 2013 Oct; 190(4):1416-20. PubMed ID: 23685097
[TBL] [Abstract][Full Text] [Related]
33. Impact of Sarcopenic Obesity on Outcomes in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma.
Kobayashi A; Kaido T; Hamaguchi Y; Okumura S; Shirai H; Yao S; Kamo N; Yagi S; Taura K; Okajima H; Uemoto S
Ann Surg; 2019 May; 269(5):924-931. PubMed ID: 29064889
[TBL] [Abstract][Full Text] [Related]
34. Poor performance of psoas muscle index for identification of patients with higher waitlist mortality risk in cirrhosis.
Ebadi M; Wang CW; Lai JC; Dasarathy S; Kappus MR; Dunn MA; Carey EJ; Montano-Loza AJ;
J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1053-1062. PubMed ID: 30269421
[TBL] [Abstract][Full Text] [Related]
35. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
BMC Cancer; 2018 Jul; 18(1):756. PubMed ID: 30041616
[TBL] [Abstract][Full Text] [Related]
36. Sarcopenic obesity assessed using dual energy X-ray absorptiometry (DXA) can predict cardiovascular disease in patients with type 2 diabetes: a retrospective observational study.
Fukuda T; Bouchi R; Takeuchi T; Tsujimoto K; Minami I; Yoshimoto T; Ogawa Y
Cardiovasc Diabetol; 2018 Apr; 17(1):55. PubMed ID: 29636045
[TBL] [Abstract][Full Text] [Related]
37. Including body composition in MELD scores improves mortality prediction among patients awaiting liver transplantation.
Hamaguchi Y; Kaido T; Okumura S; Kobayashi A; Shirai H; Yao S; Yagi S; Kamo N; Uemoto S
Clin Nutr; 2020 Jun; 39(6):1885-1892. PubMed ID: 31481263
[TBL] [Abstract][Full Text] [Related]
38. Lipid deposition in various sites of the skeletal muscles and liver exhibits a positive correlation with visceral fat accumulation in middle-aged Japanese men with metabolic syndrome.
Taira S; Shimabukuro M; Higa M; Yabiku K; Kozuka C; Ueda R; Sunagawa S; Ohshiro Y; Doi M; Nanba T; Kawamoto E; Nakayama Y; Nakamura H; Iha T; Nakachi S; Tomoyose T; Ikema T; Yamakawa K; Masuzaki H
Intern Med; 2013; 52(14):1561-71. PubMed ID: 23857087
[TBL] [Abstract][Full Text] [Related]
39. Sarcopenia associates with increased risk of hepatocellular carcinoma among male patients with cirrhosis.
Feng Z; Zhao H; Jiang Y; He Z; Sun X; Rong P; Wang W
Clin Nutr; 2020 Oct; 39(10):3132-3139. PubMed ID: 32057535
[TBL] [Abstract][Full Text] [Related]
40. Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: A retrospective cohort study.
Ninomiya G; Fujii T; Yamada S; Yabusaki N; Suzuki K; Iwata N; Kanda M; Hayashi M; Tanaka C; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Int J Surg; 2017 Mar; 39():45-51. PubMed ID: 28110029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
